Indiscriminate use of corticosteroid-containing eyedrops.
Ocular complications may occur with the use of corticosteroid-containing eyedrops. We describe two cases of corticosteroid-induced glaucoma and one case of corticosteroid-associated fungal keratitis. Corticosteroid-containing eyedrops should be avoided unless the practitioner is knowledgeable about tonometry, slit-lamp examination techniques, and ocular differential diagnosis and treatment. Alternative pharmacologic approaches to topical administration of corticosteroid-containing eyedrops are discussed.
Baratz
K H
KH
Department of Ophthalmology, Mayo Clinic Rochester, Minnesota 55905, USA.
Hattenhauer
M G
MG
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003231:Conjunctivitis / Q000209:etiology*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005670:Fusarium / Q000302:isolation & purification; D005901:Glaucoma / Q000139:chemically induced*; D005938:Glucocorticoids; D006801:Humans; D007634:Keratitis / Q000209:etiology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology* / Q000382:microbiology; D009883:Ophthalmic Solutions / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D003907:Dexamethasone